Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 303 Leukemia, Lymphocytic, Chronic, B-Cell 104 Myelodysplastic Syndromes 63 Recurrence 55 Leukemia 42 Neoplasms 41 Lymphoma, Non-Hodgkin 40 Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Lymphoma, Mantle-Cell 32 Multiple Myeloma 27 Lymphoma, Large B-Cell, Diffuse 27 Leukemia, Myelomonocytic, Chronic 27 Lymphoma, Follicular 22 Lymphoma 21 Hematologic Neoplasms 20 Lymphoma, B-Cell, Marginal Zone 18 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17 Leukemia, Biphenotypic, Acute 16 Burkitt Lymphoma 16 Myeloproliferative Disorders 11 Lymphoma, B-Cell 11 Leukemia, Myeloid 11 Neoplasm, Residual 10 Waldenstrom Macroglobulinemia 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7 Chromosome 17 deletion 6 Leukemia, B-Cell 5 Immunoglobulin Light-chain Amyloidosis 5 Breast Neoplasms 5

Interventions

palbociclib 2 Letrozole 2 Fulvestrant 2 Anastrozole 2 venetoclax 1 pyrotinib 1 pertuzumab 1 penpulimab 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Induction Chemotherapy 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Neoplasm Female × venetoclax × Clear all

NCT03900884 2024-11-07

PALVEN

Peter MacCallum Cancer Centre, Australia

Phase 1 Active not recruiting

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡